What is mitomycin C?
Mitomycin C is a drug primarily used in chemotherapy to treat a large number of cancer. In this function, it is usually administered intravenously for cancer in the head and neck, lung and breast cancer, uterine cancer and cervix, as well as rectal, thick, pancreatic and stomach cancer. It is often used as an infusion in the bladder or peritoneum as a local medicine. It is used topically after the eye surgery or eating or tracheal dilation for stenosis, it seems to reduce scarring. Mitomycin C is in several categories that provide an insight into the way it works, both in anti-cancer and anti-healing capacities. The first category, officially called immunomodulatory agents, suggests that the drug can improve or cancel the processes of the immune system. Other categories, antineoplastic agents, are for substances that can prevent or inhibit the growth of abnormal tissues.
Mitomycin C is also classified as a cytotoxic antibiotic. This means that this is an antibiOtric - A drug that can kill bacteria or slow its growth through a toxic effect on certain cells. Another characteristic of mitomycin C, which does not have a specific classification, acts as an alkylating agent by changing cell genes that are rapidly divided - as cancer cells - cause certain cells to die.
Two other functions have a genetic effect. One function is like a deceiving agent; It connects DNA chains and damages them in a way that prevents them from functioning or replication until they are repaired. The second function is to inhibit the production of cells of ribonucleic acid cells (RNA) or deoxyribonucleic acid (DNA).
people can be afraid of chemotherapy because of their side effects. Commonly known side effects of many chemotherapeutic drugs, including Mitomycinuc, are hair loss, fatigue, nausea and vomiting, loss of appetite and other stomach problems. They are unpleasantAnd somewhat debilitating but generally not endangering life. More serious side effects of mitomycin C are lung problems, especially lung fibrosis, which is the scarring of lung tissues; reduced blood cell production; and haemolytically-euro syndrome associated with cancer (C-HUS), which consists mainly of kidney and blood problems. Doctors can monitor these problems through X -rays of chest and blood and urine tests, especially those that indicate how the kidney works.
mitomycin C can be used separately as a single chemotherapeutic drug. It can also be combined with other medicines that differ according to the type of cancer treated. When fighting with metastatic rectum cancer, it can be combined with fluorouracil and leukovorin. In the treatment of small cell lung cancer can be associated with cisplatin and vindesin. Intravenous treatment is most often served for six to eight weeks.